Darbepoetin alfa is more effective than epoetin-β in suppressing hepcidin and improving iron utilization in maintenance hemodialysis patients.

Tan J, Yan H, Li X, Chen Y

Open source

DOI
10.62347/ztje6136
Published
2026
Container
American journal of translational research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.62347/ztje6136,
  title = {Darbepoetin alfa is more effective than epoetin-β in suppressing hepcidin and improving iron utilization in maintenance hemodialysis patients.},
  author = {Tan J and Yan H and Li X and Chen Y},
  year = {2026},
  journal = {American journal of translational research},
  doi = {10.62347/ztje6136},
  url = {https://doi.org/10.62347/ztje6136}
}

RIS

TY  - JOUR
TI  - Darbepoetin alfa is more effective than epoetin-β in suppressing hepcidin and improving iron utilization in maintenance hemodialysis patients.
AU  - Tan J
AU  - Yan H
AU  - Li X
AU  - Chen Y
PY  - 2026
JO  - American journal of translational research
DO  - 10.62347/ztje6136
UR  - https://doi.org/10.62347/ztje6136
ER  - 

APA

J, T., H, Y., X, L., & Y, C. (2026). Darbepoetin alfa is more effective than epoetin-β in suppressing hepcidin and improving iron utilization in maintenance hemodialysis patients.. American journal of translational research. https://doi.org/10.62347/ztje6136

Source records